Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Parasitic organism or component thereof or substance...
Patent
1981-06-02
1982-10-05
Jiles, Henry R.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Parasitic organism or component thereof or substance...
548372, A61K 31415, C07D23156
Patent
active
043528139
ABSTRACT:
A new salt of [(1-benzyl-1H-indazol-3-yl)oxy] acetic acid (or bendazac) with L. lysine.
Following oral administrations of this compound in man, the concentrations of bendazac found in the blood are higher than those obtained after administration of bendazac as such.
This discovery extends the therapeutic use of bendazac. In fact, whereas up to now bendazac could only be used topically, the L. lysine salt of bendazac makes it possible to perform therapeutic treatments with the oral route of administration as an agent with a normalizing effect on blood lipids.
REFERENCES:
patent: 3470194 (1969-09-01), Palazzo
Yabuuchi et al., Chem. Abst. 1975, vol. 82, No. 156290y.
Allori et al., Clinica Europea, 1975, vol. XIV, No. 6, pp. 1-11.
Baiocchi Leandro
Silvestrini Bruno
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.p.A.
Harkaway N.
Jiles Henry R.
LandOfFree
[(1-Benzyl-1H-indazol-3-yl)oxy] acetic acid salt with L. lysine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with [(1-Benzyl-1H-indazol-3-yl)oxy] acetic acid salt with L. lysine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and [(1-Benzyl-1H-indazol-3-yl)oxy] acetic acid salt with L. lysine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-423211